The regioselective attack on microsomal phospholipid (PL) polar heads (PH) and fatty acyl chains (FC) demonstrated in vitro has been exploited for the selective quantitation in vivo of the biochemical damages produced by the oxidation and reduction products of CHCI3 metabolism. Five hours after CHC13 injection (60 mg/kg body weight, ip) to control Sprague-Dawley rats, most of the label covalently bound in the liver was associated to PH, indicating a predominant production of COC12. The levels of radioactivity bound to both PL moieties increased proportionally when 180 mg/kg body weight 14CHC13 was administered. Buthionine sulfoximine (BSO) pretreatment resulted in a further increase of binding either to PH or FC. The pretreatment of rats with phenobarbital (PB) reduced the PH/FC binding ratio to 3.4, still indicating the predominance of the oxidative metabolism, but giving some indication of the simultaneous presence of CHCI3 reduction.When reduced glutathione (GSH) was depleted by BSO in PB-induced animals prior to 14CHCI3 administration, only the level of radioactivity associated with oxidative intermediates was increased six times.The present 3~~~~~~~~~~~~~~~~~~1 4 results confirmed that GSH is able to exert an efficient protection mainly toward CHCI3 oxidation intermediates. Furthermore, they indicate that in the liver of the Sprague-Dawley rat the major pathway of CHCI3 biotransformation is its oxidation and that pretreatment of rats with a GSH-depleting agent (such as BSO) is more relevant than PB induction in enhancing the biochemical damages produced by CHCI3 -Environ Health Perspect 102(Suppl 9): 45-47 (1994) 
Introduction
It is now widely accepted that chloroform can be both oxidized to phosgene (1, 2) and reductively biotransformed in vitro and in vivo to dichloromethyl radical (3, 4) . Either type of reactive intermediates can react in vitro with cellular structures to form covalent adducts (5) (6) (7) . Although the production of COCd2 has been associated with chloroform-induced acute toxicity (8) (9) (10) , also the reductively produced metabolites can be involved in CHCl3 toxicity. In fact, CHC13 can stimulate lipid peroxidation in PB-pretreated Sprague-Dawley microsomal phospholipids rats (11) (12) (13) , which are more susceptible to chloroform-induced hepatoxicity than control rats (14) .
It has been shown in vitro that PL are the major site of CHC13-induced damage, 
Results
After the ip administration of 60 mg/kg body weight 14CHCI3 to control male Sprague Dawley rats, most of the label covalently bound in the liver was associated to PL hydrophilic PH (Figure 1 ). Indeed the binding was about 6-fold higher than the label bound to FC. This amount of radioactivity bound either to PH or FC increased proportionally when a 3-fold higher dose (180 mg/kg body weight) was administered (Figure 1) .
When control rats were pretreated with BSO prior to 14CHCI3 administration, the effect of GSH depletion on covalent binding could be observed. The total amount of radioactivity was 7-fold higher ( Figure 2 ). The binding associated to both microsomal PL moieties resulted similarly affected (no significant changes in the ratio PH/FCassociated label). The pretreatment of rats with PB nearly doubled the total PL covalent binding due to 14CHC13 metabolites (Figure 3 ).
The radioactivity bound to FC increased slightly but significantly more than that one associated to PH.
When BSO was administered to PBinduced animals prior to 14CHC13 injection, the level of total radioactivity bound to PL was 6.5 fold increased with respect to that measured in PB-induced rat liver (7, 15) These data indicate the predominance of CHC13 oxidative metabolism, and suggest that some contribution by the reductive pathway is also present.
The marked increase of total PL binding (together with the increase of PH/FC binding ratio up to 21.8) in liver microsomes of rats pretreated with BSO indicated that GSH exerts in vivo a highly efficient scavenging action toward the CHC13 intermediate produced through the oxidative pathway. The greater susceptibility to CHC13-induced hepatotoxicity observed in GSH-depleted rats (16) may be associated mainly to a decreased protection against COC12, the major product of CHCI3 oxidation (1,2,8 ).
These preliminary results suggest that in the liver of either control or PB-induced Sprague-Dawley rats the predominant biotransformation pathway of CHC13 is its oxidation and that the damages exerted by CHC13 on the microsomal PL are potentiated by GSH-depleting agents such as BSO, more than PB-like inducers of CHC13 metabolism.
